You are here:

  1. Home
  2. NICE Guidance
  3. Conditions and diseases
  4. Musculoskeletal conditions
  5. Arthritis

Golimumab for the treatment of rheumatoid arthritis after the failure of previous disease-modifying anti-rheumatic drugs

  • Technology appraisal guidance
  • Reference number: TA225
  • Published:  22 June 2011
  • Guidance
  • Tools and resources
  • Information for the public
  • History

Response to request for re-modelling and additional information from Merck Sharp & Dohme (MSD)

Response to request for re-modelling and additional information from Merck Sharp & Dohme (MSD) Response to request for re-modelling and additional information from Merck Sharp & Dohme (MSD)
13 May 2011
(562.62 Kb 43 sec)

Adobe Acrobat reader required.

  Adobe Acrobat reader required.

This page was last updated: 12 May 2011

Back to top